Analysis of the serum factor which promotes the repopulation and differentiation of the bone marrow cell into hepatocyte.
Analysis of the serum factor which promotes the repopulation and differentiation of the bone marrow cell into hepatocyte.
批准号:
16390211
负责人:
OKITA Kiwamu
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
我们建立了GFP/CC14模型来评估骨髓细胞向肝细胞的分化。我们发现骨髓细胞(BMC)在受损肝脏中重新填充并分化为产生白蛋白的肝细胞,在这种情况下,BMC输注也显著改善了肝纤维化,提高了存活率。基于这些结果,我们开始了临床研究:自体BMC输注治疗肝硬化患者(干细胞,2006)。在此,我们通过蛋白质组学分析来寻找促进BMC向肝细胞再生和分化的血清因子。BMC输注后血清载脂蛋白明显升高。我们还分析了哪些生长因子调控BMC的再生和分化。我们发现FGF2是BMC向肝细胞再生和分化的重要生长因子。另一方面,我们也探讨了肝干细胞分化的机制。在此之前,我们还克隆了Maid作为肝干细胞分化调节因子的人类同源物。在本研究中,我们开始制作Maid KO小鼠,分析Maid如何调节BMC向肝细胞的分化。
英文摘要
We developed the GFP/CC14 model to evaluate the differentiation of bone marrow cell into hepatocyte. We found that bone marrow cell (BMC) were repopulated into the damaged liver and differentiated into albumin-producing hepatocyte In this condition, liver fibrosis was also significantly improved and survival rate was improved by BMC infusion. Depend on these results, we started the clinical study : Autologous BMC infusion therapy for liver cirrhosis patients (Stem Cells 2006). Here we did the proteomics analysis to find serum factor that promote repopulation and differentiation of BMC into hepatocyte. Apolipoprotein was increased significantly in the serum after BMC infusion. We also analyzed which growth factors regulate the repopulation and differentiation of BMC. We found that FGF2 was important growth factor to repopulate and differentiation of BMC into hepatocyte. On the other hands, we also examine the mechanism of the differentiation of liver stem cell. Previously we also cloned Human Homologue of Maid as a regulator of differentiation of hepatic stem cell. In this study, we started to make the Maid KO mouse to analyze how Maid regulate the differentiation of BMC into hepatocyte.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1053/j.gastro.2005.03.014
发表时间:
2005-05-01
期刊:
GASTROENTEROLOGY
影响因子:
29.4
作者:
[Takami, T, Terai, S, Okita, K]
通讯作者:
Okita, K
Lesson from the GFP/CCl4 model-Translational Research Project : The development of the cell therapy using autolougous bone marrow cells in liver cirrhosis patients.
GFP/CCl4 模型的教训-转化研究项目:肝硬化患者使用自体骨髓细胞进行细胞疗法的开发。
DOI:
--
发表时间:
2005
期刊:
J Hepatobiliary Pancreat Surg. (in press)
影响因子:
--
作者:
[Kazuya Matsumoto, Esaki M, Terai S]
通讯作者:
Terai S
DOI:
10.1016/j.hepres.2005.09.019
发表时间:
2005-10-01
期刊:
HEPATOLOGY RESEARCH
影响因子:
4.2
作者:
[Sakaida, I, Okita, K]
通讯作者:
Okita, K
DOI:
10.1016/j.bbrc.2003.12.044
发表时间:
2004-01
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[N. Yamamoto;S. Terai;Shinya Ohata;Tomomi Watanabe;K. Omori;K. Shinoda;K. Miyamoto;T. Katada;I. Sakaida;H. Nishina;K. Okita]
通讯作者:
N. Yamamoto;S. Terai;Shinya Ohata;Tomomi Watanabe;K. Omori;K. Shinoda;K. Miyamoto;T. Katada;I. Sakaida;H. Nishina;K. Okita
Fibroblast growth factor 2 facilitate the differentiation of transplanted bone marrow cells into hepatocytes.
成纤维细胞生长因子2促进移植的骨髓细胞分化为肝细胞。
DOI:
--
发表时间:
2006
期刊:
Cell Tissue Res. 323(2)
影响因子:
--
作者:
[Date Y, Toshinai K, Koda S, Miyazato M, Shimbara T, Tsuruta T, Niijima A, Kangawa K, Nakazato M, Ishikawa T]
通讯作者:
Ishikawa T
共 31 条
The analysis for proliferation and differentiation of hepatic stem cells
-
批准号:13470121
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.43万
-
财政年份:2001
-
负责人:OKITA Kiwamu
-
依托单位:
REGULATION OF HEPATOCYTE GROWTH
-
批准号:10470136
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.2万
-
财政年份:1998
-
负责人:OKITA Kiwamu
-
依托单位:
Hepatic regeneration and extracellular matrix
-
批准号:06454263
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1994
-
负责人:OKITA Kiwamu
-
依托单位:
Study on Regulatory Mechanism of Liver Regeneration
-
批准号:01570400
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1989
-
负责人:OKITA Kiwamu
-
依托单位:
Study on regulatory mechanism of liver regeneration
-
批准号:60570329
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1985
-
负责人:OKITA Kiwamu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CCL4促进TAM极化抑制CD8+T细胞抗肿瘤活性影响非小细胞肺癌PD-L1疗效的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
NK细胞通过CCL4/5-CCR4/5轴募集cDC1至肿瘤微环境介导PolySTING抗结直肠癌作用机制研究
-
批准号:82373279
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王建
-
依托单位:
肝细胞源性CCL4通过调控NLRP3/GSDMD介导的巨噬细胞焦亡加重肝脏缺血再灌注损伤的机制研究
-
批准号:82300724
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李萌
-
依托单位:
CCL4调控肿瘤浸润Tregs表型与功能影响EGFR-TKI获得性耐药非小细胞肺癌抗PD-1/PD-L1疗效的机制
-
批准号:82203004
-
项目类别:青年科学基金项目(C类)
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:刘桑田
-
依托单位:
TACC2通过上调趋化因子CCL3/CCL4增强软组织肉瘤抗肿瘤免疫的作用与机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨静
-
依托单位:
KEAP1 突变NSCLC 通过下调CCL4 导致 PD-1/PD-L1 抑制剂耐药的机制研究
-
批准号:21ZR1453200
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈晓霞
-
依托单位:
β-catenin信号下调CCL4表达参与食管鳞状细胞癌放疗联合免疫治疗耐受的机制研究
-
批准号:81872462
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:章文成
-
依托单位:
LMP-1抑制趋化因子CCL3/CCL4及其受体CCR介导的椎间盘内炎性细胞浸润作用的分子机制研究
-
批准号:81572175
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2015
-
负责人:郑召民
-
依托单位: